Catalent today announced the appointment of two General Managers to oversee key Clinical Supply Services facilities in its European network.
Somerset, N.J. – January 7, 2015 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has today announced the appointment of two General Managers to oversee key Clinical Supply Services facilities in its European network.
Mr. Alan Robinson has been appointed to oversee operations at the company’s Bolton and Deeside, UK facilities. In this new role, Mr. Robinson will drive uptake in the Clinical Supply Services provided by both sites, and leverage their complementary expertise to provide innovative solutions to customers.
“The Bolton and Deeside sites operate very much like sister facilities due to their close proximity and mirrored and complementary capabilities. This appointment allows Mr. Robinson to leverage the breadth of services and technical expertise across both sites to the benefit of our customers,” commented Stuart Cryer, Vice President, Operations, Development and Clinical Services, Europe and Rest of World for Catalent.
A 30-year industry veteran, Mr. Robinson’s areas of expertise include operations management, strategic planning, and the application of continuous performance improvement methodologies, including Six Sigma and Lean Manufacturing. He was formerly Senior Director and Site Head for Aptuit.In a second announcement, Mr. Roel de Nobel has been appointed General Manager of Catalent’s Schorndorf, Germany Clinical Supply Services facility, and will focus on driving operational excellence to support clients’ clinical trial needs. Mr. de Nobel brings more than 20 years of experience in logistics, supply chain and financial management to Catalent, most recently as the Global Director, Logistics Management for Carl ZEISS AG.
“Mr. de Nobel has an impressive operations and supply chain track record in highly complex businesses, and we are very pleased to welcome him to Catalent to lead our Schorndorf operations,” added Stuart Cryer.
Catalent currently supports the clinical trial supply needs of nearly all of the top 25 pharmaceutical companies and more than 300 small innovators from all over the world. With facilities located in the US, Europe and Asia/Pacific regions, and covering six continents with extensive, strategically located depots, Catalent Clinical Supply Services has a robust network built around the most complete, integrated service offerings for pharmaceuticals in clinical trial phases I-IV.
+44 (0)7580 041073
+44 (0) 161 728 5880
Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,000 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and in fiscal 2014 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com